Harmonization of Ph.Eur. 2.2.46 and USP 621 – New Allowed Adjustments
Webinar Date/Time: Wed, May 31, 2023 11:00 AM EDT
Heiko Behr from Phenomenex will provide an overview of the allowable adjustments for both the Ph. Eur. 2.2.46 and USP h. Eur621. This webinar will demonstrate how to update or modernize your methods, and utilize the recommended columns to obtain results that meet the system suitability for each method.
Register Free: https://www.chromatographyonline.com/lcgc_w/harmonization
Event Overview:
Heiko Behr from Phenomenex will provide an overview of current LC methods and solutions for the evolving pharmaceutical market. With new revisions to both the Ph. Eur. 2.2.46 and USP 621, the criteria for allowable adjustments requires harmonization across Pharmacopeia, the European Pharmacopoeia, US Pharmacopeia, and Japanese Pharmacopeia. This webinar will demonstrate how to develop and adjust your methods as well as how to utilize the recommended columns to obtain results that meet the system suitability of the regulation methods for Ph. Eur. 2.2.46 and USP 621.
Key Learning Objectives:
- Harmonization of Ph. Eur. Chapter 2.2.46 and USP General Chapter 621
- Review revisions to the allowed adjustments of chromatographic conditions and new parameters of chromatographic tests, specifically for Ph. Eur. 2.2.46 and USP 621
- Learn about regulations of isocratic and gradient elution in HPLC
- Explore criteria for system suitability for these regulated methods
Who Should Attend
- Any HPLC scientists wanting to learn about the latest revisions around the allowable adjustments for HPLC.
- Anyone in a pharma company wanting to learn about new technologies and solutions.
Speaker:
Heiko Behr
Senior Business Development Manager
Phenomenex
Dr. Heiko Behr has over 30 years of experience in chromatography and is currently the European Pharmaceutical Senior Business Development Manager at Phenomenex. His primary responsibilities are consulting with pharmaceutical scientists to determine the best implementation of new HPLC technologies. He also gives educational seminars about method development, troubleshooting, system optimizations and the like. In addition, he is responsible for European Pharmacopeia Projects at Phenomenex globally.
Prior to joining Phenomenex, Dr. Behr graduated with a diploma in chemistry at the University of Kassel and received his Ph.D. in analytical chemistry at the Technical University of Munich under the advisement of Professor Harun Parlar, with the main focus being chromatography theory and techniques. From 1993 to 1998, he was involved in teaching chromatography techniques to students at the University of Kassel in his function as a scientific assistant of the analytical chemistry department. Dr. Behr joined Phenomenex as a Technical Consultant in 1999. Since then, he has also been the Senior Product Specialist for HPLC columns in Germany/Austria andSales and Business Development Manager for European Distributors.
Register Free: https://www.chromatographyonline.com/lcgc_w/harmonization
Advances in Non-Targeted Analysis for PFAS in Environmental Matrices
March 27th 2025David Megson from Manchester Metropolitan University in Manchester, UK, spoke to LCGC International about the latest developments in non-targeted analysis (NTA) of per- and polyfluoroalkyl substances (PFAS) in environmental matrices based on a recent systematic review paper he has collaboratively published (1).
Study Explores Thin-Film Extraction of Biogenic Amines via HPLC-MS/MS
March 27th 2025Scientists from Tabriz University and the University of Tabriz explored cellulose acetate-UiO-66-COOH as an affordable coating sorbent for thin film extraction of biogenic amines from cheese and alcohol-free beverages using HPLC-MS/MS.
Multi-Step Preparative LC–MS Workflow for Peptide Purification
March 21st 2025This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid chromatography–mass spectrometry (LC–MS). The process involves optimizing separation conditions, scaling-up, fractionating, and confirming purity and recovery, using a single LC–MS system. High purity and recovery rates for synthetic peptides such as parathormone (PTH) are achieved. The method allows efficient purification and accurate confirmation of peptide synthesis and is suitable for handling complex preparative purification tasks.
